GO
Loading...

Medicine

More

  • Ebola is 'contained' in Nigeria: Health minister Tuesday, 26 Aug 2014 | 12:05 PM ET
    A pharmacist searches for drugs in a pharmacy in Lagos, Nigeria, July 26, 2014.

    Nigeria's health minister has insisted the Ebola outbreak has been contained in the country.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Aug 25- Drug developer Kite Pharma Inc said its experimental cancer immunotherapy showed potential in treating patients with an aggressive form of blood cancer, in an early-stage study. In one arm of the study, funded by Kite and conducted by National Cancer Institute, 15 patients were given the therapy.

  • BUZZ-: KITE PHARMA INC: LEAD CANCER DRUG SHOWS PROMISE IN. **Cancer drug developer's shares up 31.2 pct at $29.25 in extended trade. **Says its lead drug has potential to treat aggressive form of blood cancer.

  • Aug 25- Drug developer Kite Pharma Inc said its experimental cancer therapy showed potential in treating patients in an early-stage study. The company's lead drug, KTE-C19, is being developed to fight an aggressive form of blood cancer. Kite's shares were up 35.2 percent at $33.33 in extended trading.

  • WINNIPEG, Manitoba, Aug 25- Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring.

  • Roche's blockbuster pharma deal     Monday, 25 Aug 2014 | 3:47 PM ET

    CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.

  • Aug 25- Four monkeys survived the Ebola virus after being injected with Immunovaccine Inc's experimental vaccine, the tiny Canadian company said on Monday, an announcement that sent its stock soaring. The tests were performed by the U.S. Health Department's National Institutes of Health, based in Maryland.

  • Roche CEO: InterMune perfect strategic fit     Monday, 25 Aug 2014 | 11:18 AM ET

    CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

  • LOS ANGELES, Aug 25- U.S. regulators are likely to approve Merck& Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.

  • British Ebola patient to be evacuated: Official Sunday, 24 Aug 2014 | 4:05 AM ET

    The first British citizen confirmed to be infected with the deadly Ebola disease is being evacuated from Sierra Leone.

  • A look at this week's ice bucket challenges to raise awareness and donations for the ALS Association. Watch Rod Stewart and Rudy Gay dump Vivek Ranadivé, Chris Mullin, and Sunil Gulati.

  • ATLANTA, Aug 21- Appearing thin but smiling, a Texas doctor who weeks ago entered an Atlanta hospital in a full-body biohazard suit to be treated for Ebola said on Thursday he was "thrilled to be alive" as doctors declared him virus-free and safe for release.

  • ATLANTA, Aug 21- Two American aid workers who just weeks ago were gravely ill with Ebola they contracted in Liberia now pose no health risk to the public after being cleared of the virus and released from an Atlanta hospital, one of their doctors said on Thursday.

  • ATLANTA, Aug 21- Two American aid workers discharged from an Atlanta hospital after being treated for Ebola pose no health risk to the public, an Emory University Hospital doctor said on Thursday.

  • JOHANNESBURG, Aug 21- Surviving sickness can make you stronger. "If anything, I think it is teaching us something," Mustapha Sidiki Kaloko, the African Union's Commissioner for Social Affairs, told reporters in Addis Ababa this month.

  • Aug 21- Eli Lilly and Co said its experimental psoriasis drug was found to be more effective in clearing skin than a generic treatment and a placebo in late-stage studies. The most common inflammatory disease in the United States- it can occur on any part of the body- it is associated with diabetes and heart disease.

  • ABIDJAN, Aug 21- An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has recovered and will be discharged on Thursday by the U.S. hospital that treated him with an experimental drug, his charity said.

  • NEW YORK, Aug 20- An experimental drug from Tekmira Pharmaceuticals Corp helped lab monkeys recover from the most deadly strain of Marburg virus, a close cousin of Ebola, even after symptoms appeared, scientists reported on Wednesday.

  • MONROVIA, Aug 20- Police in the Liberian capital Monrovia fired tear gas on Wednesday to disperse a stone-throwing crowd agitating to leave a neighbourhood placed under quarantine because of the Ebola virus, witnesses said. The rundown area has been hit by Ebola, which has killed more than 1,200 people in Guinea, Sierra Leone and Liberia and five in Nigeria.